More than 20% of the U.S. population suffers from migraines and their debilitating and painful effects. Together, we can bring much-needed awareness to the community about how to manage this very common condition and help break the stigma that is...
6-1-2022
World Mental Health Month is observed every year with the overall objective of raising awareness of mental health issues around the world and mobilizing efforts in support of mental health. The initiative provides an opportunity for all stakeholders working on...
5-1-2022
SAN JUAN, PR — Abarca Health celebrated the first annual Abarca Forward event, a healthcare industry summit that hosted dozens of industry leaders from across the country. Industry experts were invited to discuss trends, best practices, and the vision of...
4-28-2022
April is World's Parkinson's Awareness Month and Abarca goes #allin to bring support and awareness to this condition. Today, Parkinson's Disease affects one million people in the U.S alone and studies show these numbers will rise to 1.2 million by...
3-31-2022
When Paul Chan joined our team as the VP of Product, he brought nearly 15 years of experience in the PBM industry–and a passion for making healthcare work better for everyone. Now, with almost a year as an Abarcan under...
3-11-2022
Over millions of people in the U.S alone suffer from chronic pains caused by arthritis. One in four adults reports having severe joint pain. Learning about the pain and how to manage it is half the battle. Did you also...
3-11-2022
Meet Darwin’s new Drug Review Tool! With this solution, Abarca clients and Darwin™ users may access real-time information on drug maintenance and will have full visibility of ongoing medication changes to health plan formularies. What were the challenges users were...
2-25-2022
After several clinical trials associated with SGLT-2 inhibitors, this anti-diabetic drug class of medications is now linked to providing beneficial impacts on cardiovascular disease. Sodium-glucose cotransporter-2 inhibitors, also known as SGLT2 inhibitors, are antidiabetic drug classes that exert their function...
2-24-2022
Each February, Abarca joins the NHLBI and The Heart Truth® to celebrate American Heart Month by motivating Americans to adopt healthy lifestyles to prevent heart disease. Focusing on your heart health has never been more important. People with poor cardiovascular...
2-10-2022
As we close out the second year of the COVID-19 pandemic, it is easy to see that we are in a very different place in terms of testing and treatments than we were in 2020. In particular, there are now...
1-24-2022
